{"id":7684,"date":"2022-12-20T12:49:17","date_gmt":"2022-12-20T12:49:17","guid":{"rendered":"https:\/\/www.emr-online.com\/?p=7684"},"modified":"2022-12-21T13:00:42","modified_gmt":"2022-12-21T13:00:42","slug":"ahlsell-regulatory-approvals-obtained-for-the-acquisition-of-sanistal","status":"publish","type":"post","link":"https:\/\/www.emr-online.com\/ahlsell-regulatory-approvals-obtained-for-the-acquisition-of-sanistal\/","title":{"rendered":"Ahlsell – Regulatory approvals obtained for the acquisition of Sanist\u00e5l"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]<\/p>\n

\"\"On 24 May 2022, Ahlsell Danmark ApS (\u201cAhlsell\u201d) announced that Ahlsell had entered into conditional share purchase agreements (\u201cShare Purchase Agreements\u201d) with Danske Bank A\/S, Nordea Bank Abp, Jyske Bank A\/S and Nykredit Bank A\/S (the \u201cMajor Shareholders\u201d) to acquire approximately 75.49% of the shares in Sanist\u00e5l A\/S (\u201cSanist\u00e5l\u201d) at a price of DKK 58 per share.\u00a0<\/strong><\/h4>\n

 <\/p>\n

In addition, Ahlsell announced that it would make a recommended conditional voluntary public offer (the \u201cOffer\u201d) to purchase the remaining approximately 24.51% of the shares held by all shareholders other than the Major Shareholders (the \u201cMinority Shareholders\u201d) at a price of DKK 85 per share.<\/p>\n

The aforementioned acquisitions are conditional upon, inter alia, the Share Purchase Agreements having been completed in accordance with their terms, which is conditional upon all necessary approvals, permits and consents from relevant authorities having been obtained.<\/p>\n

Ahlsell has today notified the Major Shareholders and Sanist\u00e5l that it has received the necessary regulatory approvals to complete the Share Purchase Agreements and that Ahlsell will proceed to close the Share Purchase Agreements as soon as possible. Accordingly, Ahlsell has further notified Sanist\u00e5l that to its knowledge, all conditions of the Offer are satisfied or are capable of being satisfied upon expiry of the offer period and completion of the Offer.<\/p>\n

The offer period expires on 22 December 2022 at 5:00 p.m. (CET).<\/p>\n

Further information about the completion of the Share Purchase Agreements and the Offer will be announced in due course by Sanist\u00e5l via Nasdaq Copenhagen A\/S.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Source<\/strong>
\nAhlsell<\/a><\/h5>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=”50px”][\/vc_column][\/vc_row][vc_row el_class=”bg_wt_rc”][vc_column][vc_column_text]<\/p>\n

EMR Analysis<\/strong><\/h4>\n
\n

 <\/p>\n

\n

More information on Ahlsell:<\/strong>\u00a0See full profile on EMR Executive Services<\/p>\n

More information on Claes Seldeby (Group CEO, Ahlsell AB):<\/strong>\u00a0See the full profile on EMR Executive Services<\/p>\n

More information on Ahlsell Danmark ApS:<\/strong>\u00a0https:\/\/www.ahlsell.dk\/<\/a>\u00a0+ Brief facts about Ahlsell Denmark:<\/p>\n